Content about alternative therapies

December 17, 2012

The Food and Drug Administration has approved a new biotech drug from GlaxoSmithKline for anthrax, the drug maker said.

LONDON — The Food and Drug Administration has approved a new biotech drug from GlaxoSmithKline for anthrax, the drug maker said.

GSK announced the approval of raxibacumab for adults and children who have inhaled Bacillus anthracis. The drug is designed for combination with antibiotics and for preventing inhalational anthrax when alternative therapies aren't available. The drug is the result of a project that Human Genome Sciences, now owned by GSK, began working on in 2001 in response to terrorist anthrax attacks in the United States.

April 25, 2011

The new Pharmaca stores make a very bold statement about the relationship between pharmacy and prevention. The company unveiled its new store design in Menlo Park, Calif., in November 2010. The 6,800-sq.-ft. store continues Pharmaca’s “integrative pharmacy” model, which emphasizes holistic approaches to health care and features eight licensed practitioners.